Antidepressant promising for tension headaches

Fri Apr 13, 2007 9:36pm EDT
 
[-] Text [+]

NEW YORK (Reuters Health) - For some patients seeking relief from frequent tension-type headaches, the antidepressant Effexor XR may reduce the number of days with headache, according to results of a small study conducted in Greece.

The team of researchers, led by Dr. N. P. Zissis, at Wyeth Hellas in Athens, recruited patients with tension headaches that occurred more often than on five days per month.

The 60 participants were randomly assigned to Effexor (known generically as venlafaxine) XR or an inactive placebo. They could also take aspirin or paracetamol/acetaminophen but no other pain killers, according to a report in the medical journal Cephalalgia.

At the end of the 12-week trial, the average reduction in the numbers of days with headache was significantly greater in the venlafaxine group (45 percent) compared with the placebo group (16 percent).

The total hours of headache and headache intensity also improved more with active treatment, but the differences were not significant from a statistical standpoint.

This pilot study suggests that "treatment with venlafaxine XR was generally safe and, compared with placebo, resulted in less days with tension-type headache," Dr. Zissis and colleagues conclude.

SOURCE: Cephalalgia, April 2007.

 
Dr. Qurrath U. Ain of the Elmhurst Pediatric Emergency Center examines a patient with flu-like symptoms at Elmhurst Hospital in New York in this December 12, 2003. file photo. REUTERS/Shannon Stapleton/Files
Healthcare Reform

Reuters provides an in-depth look at the issues facing Americans as the Obama administration wrestles with healthcare policy.  Full Coverage 

Editor's Choice

A selection of our best photos from the past 24 hours.  Slideshow 

Most Popular on Reuters

  • Articles
  • Video
Uninsured patient Josefa Martinez, 8, has her blood pressure measured during a health check-up at Venice Family Clinic in Venice, California, June 25, 2009.  REUTERS/Lucy Nicholson
The healthcare disconnect

A successful reform package will have to address the cost for services for private versus public providers and employ innovative technological advances, writes Darrell West, author of Digital Medicine: Health Care in the Internet Era.  Commentary | Full Coverage 

Join the Reuters Consumer Insight Panel and help us get to know you better

Join the Reuters Consumer Insight Panel and help us get to know you better